» Articles » PMID: 37092088

The Evaluation of Risk Factors Related to Reduced Bone Mineral Density in Young People Living with HIV

Overview
Journal Afr Health Sci
Date 2023 Apr 24
PMID 37092088
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Low bone mineral density (BMD) is one of the comorbidities that develop in people living with HIV (PLWHIV).

Objective: This study was conducted to review the frequency and risk factors of reduced BMD according to age in HIV-infected patients in Turkey.

Material And Method: This retrospective cohort study included HIV-infected patients aged 18-50. Bone density was analysed using dual-energy X-ray absorptiometry (DXA) according to the Z-score in three different regions including the lumbar, total-hip and femoral-neck.

Results: The study included 224 PLWHIV with a mean age of 35.84-7.54, and 59.8% were ART naive. Of the patients, 40.6% had lower BMD than expected at least in one of the three examined regions including the lumbar, total hip and femoral neck. The low BMD ratios were found respectively as 11.6%, 11.6% and 28.6% in the femoral neck, total hip and lumbar regions. According to the logistic regression model, a high body mass index (p=0.003) and HIV-RNA level of ≥100.000IU/ml during the diagnosis in the ART-naive group (p=0.008) were associated with reduced bone demineralization. The low BMD frequency was high in the group that received ART for <24 months (p=0.001).

Conclusion: Performing bone demineralization screening in the naive and young patient group, independently from ART status prior to making the diagnosis of HIV is important for organizing the bone health improvement methods.

Citing Articles

Risk Factors Associated with Osteopenia/Osteoporosis in Antiretroviral Therapy Naive HIV Patients.

Onguru P, Kaya B Curr HIV Res. 2024; 22(4):259-265.

PMID: 38899524 DOI: 10.2174/011570162X311238240603042806.


Editorial: Non-communicable diseases; sexual reproductive issues; infectious diseases and health systems challenges.

Tumwine J Afr Health Sci. 2023; 22(4):i-v.

PMID: 37092096 PMC: 10117524. DOI: 10.4314/ahs.v22i4.1.

References
1.
Chitu-Tisu C, Barbu E, Lazar M, Ion D, Badarau I . Low bone mineral density and associated risk factors in HIV-infected patients. Germs. 2016; 6(2):50-9. PMC: 4956161. DOI: 10.11599/germs.2016.1089. View

2.
Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino J, White D . Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015; 16 Suppl 1:137-46. PMC: 4341957. DOI: 10.1111/hiv.12242. View

3.
Cervero M, Torres R, Agud J, Alcazar V, Jusdado J, Garcia-Lacalle C . Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients. PLoS One. 2018; 13(4):e0196201. PMC: 5927434. DOI: 10.1371/journal.pone.0196201. View

4.
Bolland M, Grey A, Gamble G, Reid I . CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2007; 92(12):4522-8. DOI: 10.1210/jc.2007-1660. View

5.
Jimenez-Sousa M, Martinez I, Medrano L, Fernandez-Rodriguez A, Resino S . Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease. Front Immunol. 2018; 9:458. PMC: 5857570. DOI: 10.3389/fimmu.2018.00458. View